New federal policy changes are set to significantly alter Medicaid financing, with the Centers for Medicare and Medicaid Services (CMS) projecting a $510 billion reduction in federal spending between 2026 …
Tag:
hospitals
-
-
Immigrants currently represent approximately 19% of the U.S. workforce, playing a critical role in the health care, construction, and agricultural sectors. Recent data from the U.S. Bureau of Labor Statistics …
-
Eli Lilly and Company is changing its distribution strategy for Mounjaro and Zepbound to mitigate what it identifies as “duplicate discounts” involving contract pharmacies. Starting October 1, 2024, the manufacturer …
-
Immigrant Physicians Face Growing Uncertainty Amid Shifting U.S. Immigration Policies Federal immigration policy fluctuations and evolving visa requirements are creating significant professional instability for international medical graduates (IMGs) and medical …
-
Health
Medicaid Spending on State Directed Payments: Analysis of Federal, State, and Provider Impacts
Medicaid State Directed Payments Face $911 Billion Federal Spending Reduction New federal legislation will reduce Medicaid spending by an estimated $911 billion between 2025 and 2034, largely by placing stricter …
-
Indiana Hospital Price Caps: Understanding the New Limitations on Healthcare Costs Starting July 1, 2024, five of Indiana’s largest nonprofit hospital systems are prohibited from charging patients with employer-sponsored health …
-
Healthcare Billing Companies Expand Influence at Hospital Finance Conference At this week’s annual meeting of hospital finance leaders, billing and collections companies accounted for nearly 40% of exhibit space, according …
-
Health
Qatar’s Liquefied Natural Gas Facilities Hit by Strikes Amid Global Helium Shortage Concerns for MRI Scanners
Strikes on Qatar’s Helium Facilities Threaten MRI Operations as Global Supply Chain Disruptions Escalate Strikes on Qatar’s liquefied natural gas facilities, linked to the U.S.-Israel military campaign against Iran, have …
-
Low-Dose Naltrexone Fails to Improve Fibromyalgia Outcomes in Clinical Trial A recent 12-month, randomized, double-blind, placebo-controlled trial has found that low-dose naltrexone (LDN) does not outperform a placebo in reducing …
-
The Evolution of Scientific Discovery: How LILA is Redefining Autonomous Research In the fast-paced world of modern innovation, the bridge between raw data and breakthrough discovery is narrowing. As we …